Global and Japan Pre-Implantation Genetic Diagnosis (PGD) Market Size, Status and Forecast 2024-2031

Report ID: 1024450 | Published Date: Jan 2025 | No. of Page: 107 | Base Year: 2024 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Chromosomal Abnormalities
        1.2.3 X-linked Diseases
        1.2.4 Freeze Embryo Testing
        1.2.5 Aneuploidy Screening
        1.2.6 HLA
        1.2.7 Others
    1.3 Market by Application
        1.3.1 Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Stem Cell Therapy
        1.3.3 IVF Prognosis
        1.3.4 Late-Onset Genetic Disorders
        1.3.5 Inherited Genetic Disease
        1.3.6 Others
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Pre-Implantation Genetic Diagnosis (PGD) Market Perspective (2016-2027)
    2.2 Pre-Implantation Genetic Diagnosis (PGD) Growth Trends by Regions
        2.2.1 Pre-Implantation Genetic Diagnosis (PGD) Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Pre-Implantation Genetic Diagnosis (PGD) Historic Market Share by Regions (2016-2021)
        2.2.3 Pre-Implantation Genetic Diagnosis (PGD) Forecasted Market Size by Regions (2022-2027)
    2.3 Pre-Implantation Genetic Diagnosis (PGD) Industry Dynamic
        2.3.1 Pre-Implantation Genetic Diagnosis (PGD) Market Trends
        2.3.2 Pre-Implantation Genetic Diagnosis (PGD) Market Drivers
        2.3.3 Pre-Implantation Genetic Diagnosis (PGD) Market Challenges
        2.3.4 Pre-Implantation Genetic Diagnosis (PGD) Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Pre-Implantation Genetic Diagnosis (PGD) Players by Revenue
        3.1.1 Global Top Pre-Implantation Genetic Diagnosis (PGD) Players by Revenue (2016-2021)
        3.1.2 Global Pre-Implantation Genetic Diagnosis (PGD) Revenue Market Share by Players (2016-2021)
    3.2 Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Pre-Implantation Genetic Diagnosis (PGD) Revenue
    3.4 Global Pre-Implantation Genetic Diagnosis (PGD) Market Concentration Ratio
        3.4.1 Global Pre-Implantation Genetic Diagnosis (PGD) Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Pre-Implantation Genetic Diagnosis (PGD) Revenue in 2020
    3.5 Pre-Implantation Genetic Diagnosis (PGD) Key Players Head office and Area Served
    3.6 Key Players Pre-Implantation Genetic Diagnosis (PGD) Product Solution and Service
    3.7 Date of Enter into Pre-Implantation Genetic Diagnosis (PGD) Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Pre-Implantation Genetic Diagnosis (PGD) Breakdown Data by Type
    4.1 Global Pre-Implantation Genetic Diagnosis (PGD) Historic Market Size by Type (2016-2021)
    4.2 Global Pre-Implantation Genetic Diagnosis (PGD) Forecasted Market Size by Type (2022-2027)

5 Pre-Implantation Genetic Diagnosis (PGD) Breakdown Data by Application
    5.1 Global Pre-Implantation Genetic Diagnosis (PGD) Historic Market Size by Application (2016-2021)
    5.2 Global Pre-Implantation Genetic Diagnosis (PGD) Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Pre-Implantation Genetic Diagnosis (PGD) Market Size (2016-2027)
    6.2 North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type
        6.2.1 North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2016-2021)
        6.2.2 North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2022-2027)
        6.2.3 North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2016-2027)
    6.3 North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application
        6.3.1 North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2016-2021)
        6.3.2 North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2022-2027)
        6.3.3 North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2016-2027)
    6.4 North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country
        6.4.1 North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2016-2021)
        6.4.2 North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size (2016-2027)
    7.2 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type
        7.2.1 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2016-2021)
        7.2.2 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2022-2027)
        7.2.3 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2016-2027)
    7.3 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application
        7.3.1 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2016-2021)
        7.3.2 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2022-2027)
        7.3.3 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2016-2027)
    7.4 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country
        7.4.1 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2016-2021)
        7.4.2 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size (2016-2027)
    8.2 Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type
        8.2.1 Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2016-2027)
    8.3 Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application
        8.3.1 Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2016-2027)
    8.4 Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size by Region
        8.4.1 Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size (2016-2027)
    9.2 Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type
        9.2.1 Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2016-2021)
        9.2.2 Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2022-2027)
        9.2.3 Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2016-2027)
    9.3 Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application
        9.3.1 Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2016-2021)
        9.3.2 Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2022-2027)
        9.3.3 Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2016-2027)
    9.4 Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country
        9.4.1 Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2016-2021)
        9.4.2 Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size (2016-2027)
    10.2 Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type
        10.2.1 Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2016-2027)
    10.3 Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application
        10.3.1 Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2016-2027)
    10.4 Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country
        10.4.1 Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Roche
        11.1.1 Roche Company Details
        11.1.2 Roche Business Overview
        11.1.3 Roche Pre-Implantation Genetic Diagnosis (PGD) Introduction
        11.1.4 Roche Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021)
        11.1.5 Roche Recent Development
    11.2 Genea Limited
        11.2.1 Genea Limited Company Details
        11.2.2 Genea Limited Business Overview
        11.2.3 Genea Limited Pre-Implantation Genetic Diagnosis (PGD) Introduction
        11.2.4 Genea Limited Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021)
        11.2.5 Genea Limited Recent Development
    11.3 Quest Diagnostics
        11.3.1 Quest Diagnostics Company Details
        11.3.2 Quest Diagnostics Business Overview
        11.3.3 Quest Diagnostics Pre-Implantation Genetic Diagnosis (PGD) Introduction
        11.3.4 Quest Diagnostics Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021)
        11.3.5 Quest Diagnostics Recent Development
    11.4 Illumina, Inc.
        11.4.1 Illumina, Inc. Company Details
        11.4.2 Illumina, Inc. Business Overview
        11.4.3 Illumina, Inc. Pre-Implantation Genetic Diagnosis (PGD) Introduction
        11.4.4 Illumina, Inc. Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021)
        11.4.5 Illumina, Inc. Recent Development
    11.5 Natera, Inc.
        11.5.1 Natera, Inc. Company Details
        11.5.2 Natera, Inc. Business Overview
        11.5.3 Natera, Inc. Pre-Implantation Genetic Diagnosis (PGD) Introduction
        11.5.4 Natera, Inc. Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021)
        11.5.5 Natera, Inc. Recent Development
    11.6 Cooper Medical, Inc.
        11.6.1 Cooper Medical, Inc. Company Details
        11.6.2 Cooper Medical, Inc. Business Overview
        11.6.3 Cooper Medical, Inc. Pre-Implantation Genetic Diagnosis (PGD) Introduction
        11.6.4 Cooper Medical, Inc. Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021)
        11.6.5 Cooper Medical, Inc. Recent Development
    11.7 LabCorp
        11.7.1 LabCorp Company Details
        11.7.2 LabCorp Business Overview
        11.7.3 LabCorp Pre-Implantation Genetic Diagnosis (PGD) Introduction
        11.7.4 LabCorp Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021)
        11.7.5 LabCorp Recent Development
    11.8 California Pacific Medical Center (CPMC)
        11.8.1 California Pacific Medical Center (CPMC) Company Details
        11.8.2 California Pacific Medical Center (CPMC) Business Overview
        11.8.3 California Pacific Medical Center (CPMC) Pre-Implantation Genetic Diagnosis (PGD) Introduction
        11.8.4 California Pacific Medical Center (CPMC) Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021)
        11.8.5 California Pacific Medical Center (CPMC) Recent Development
    11.9 Thermo Fisher Scientific Inc.
        11.9.1 Thermo Fisher Scientific Inc. Company Details
        11.9.2 Thermo Fisher Scientific Inc. Business Overview
        11.9.3 Thermo Fisher Scientific Inc. Pre-Implantation Genetic Diagnosis (PGD) Introduction
        11.9.4 Thermo Fisher Scientific Inc. Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021)
        11.9.5 Thermo Fisher Scientific Inc. Recent Development
    11.10 IGENOMIX
        11.10.1 IGENOMIX Company Details
        11.10.2 IGENOMIX Business Overview
        11.10.3 IGENOMIX Pre-Implantation Genetic Diagnosis (PGD) Introduction
        11.10.4 IGENOMIX Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021)
        11.10.5 IGENOMIX Recent Development
    11.11 Reproductive Genetic Innovations
        11.11.1 Reproductive Genetic Innovations Company Details
        11.11.2 Reproductive Genetic Innovations Business Overview
        11.11.3 Reproductive Genetic Innovations Pre-Implantation Genetic Diagnosis (PGD) Introduction
        11.11.4 Reproductive Genetic Innovations Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021)
        11.11.5 Reproductive Genetic Innovations Recent Development
    11.12 CombiMatrix
        11.12.1 CombiMatrix Company Details
        11.12.2 CombiMatrix Business Overview
        11.12.3 CombiMatrix Pre-Implantation Genetic Diagnosis (PGD) Introduction
        11.12.4 CombiMatrix Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021)
        11.12.5 CombiMatrix Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Chromosomal Abnormalities
    Table 3. Key Players of X-linked Diseases
    Table 4. Key Players of Freeze Embryo Testing
    Table 5. Key Players of Aneuploidy Screening
    Table 6. Key Players of HLA
    Table 7. Key Players of Others
    Table 8. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 9. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 10. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size by Regions (2016-2021) & (US$ Million)
    Table 11. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Regions (2016-2021)
    Table 12. Global Pre-Implantation Genetic Diagnosis (PGD) Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 13. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Regions (2022-2027)
    Table 14. Pre-Implantation Genetic Diagnosis (PGD) Market Trends
    Table 15. Pre-Implantation Genetic Diagnosis (PGD) Market Drivers
    Table 16. Pre-Implantation Genetic Diagnosis (PGD) Market Challenges
    Table 17. Pre-Implantation Genetic Diagnosis (PGD) Market Restraints
    Table 18. Global Pre-Implantation Genetic Diagnosis (PGD) Revenue by Players (2016-2021) & (US$ Million)
    Table 19. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Players (2016-2021)
    Table 20. Global Top Pre-Implantation Genetic Diagnosis (PGD) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pre-Implantation Genetic Diagnosis (PGD) as of 2020)
    Table 21. Ranking of Global Top Pre-Implantation Genetic Diagnosis (PGD) Companies by Revenue (US$ Million) in 2020
    Table 22. Global 5 Largest Players Market Share by Pre-Implantation Genetic Diagnosis (PGD) Revenue (CR5 and HHI) & (2016-2021)
    Table 23. Key Players Headquarters and Area Served
    Table 24. Key Players Pre-Implantation Genetic Diagnosis (PGD) Product Solution and Service
    Table 25. Date of Enter into Pre-Implantation Genetic Diagnosis (PGD) Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2016-2021) (US$ Million)
    Table 28. Global Pre-Implantation Genetic Diagnosis (PGD) Revenue Market Share by Type (2016-2021)
    Table 29. Global Pre-Implantation Genetic Diagnosis (PGD) Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 30. Global Pre-Implantation Genetic Diagnosis (PGD) Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 31. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Share by Application (2016-2021) & (US$ Million)
    Table 32. Global Pre-Implantation Genetic Diagnosis (PGD) Revenue Market Share by Application (2016-2021)
    Table 33. Global Pre-Implantation Genetic Diagnosis (PGD) Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 34. Global Pre-Implantation Genetic Diagnosis (PGD) Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 35. North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2016-2021) (US$ Million)
    Table 36. North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2022-2027) & (US$ Million)
    Table 37. North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2016-2021) (US$ Million)
    Table 38. North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2022-2027) & (US$ Million)
    Table 39. North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2016-2021) & (US$ Million) 
    Table 40. North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2022-2027) & (US$ Million) 
    Table 41. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2016-2021) (US$ Million)
    Table 42. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2022-2027) & (US$ Million)
    Table 43. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2016-2021) (US$ Million)
    Table 44. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2022-2027) & (US$ Million)
    Table 45. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2016-2021) & (US$ Million) 
    Table 46. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2022-2027) & (US$ Million) 
    Table 47. Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2016-2021) (US$ Million)
    Table 48. Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2022-2027) & (US$ Million)
    Table 49. Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2016-2021) (US$ Million)
    Table 50. Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2022-2027) & (US$ Million)
    Table 51. Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size by Region (2016-2021) & (US$ Million) 
    Table 52. Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size by Region (2022-2027) & (US$ Million) 
    Table 53. Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2016-2021) (US$ Million)
    Table 54. Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2022-2027) & (US$ Million)
    Table 55. Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2016-2021) (US$ Million)
    Table 56. Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2022-2027) & (US$ Million)
    Table 57. Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2016-2021) & (US$ Million) 
    Table 58. Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2022-2027) & (US$ Million) 
    Table 59. Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2016-2021) (US$ Million)
    Table 60. Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2022-2027) & (US$ Million)
    Table 61. Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2016-2021) (US$ Million)
    Table 62. Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2022-2027) & (US$ Million)
    Table 63. Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2016-2021) & (US$ Million) 
    Table 64. Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2022-2027) & (US$ Million) 
    Table 65. Roche Company Details
    Table 66. Roche Business Overview
    Table 67. Roche Pre-Implantation Genetic Diagnosis (PGD) Product
    Table 68. Roche Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021) & (US$ Million)
    Table 69. Roche Recent Development
    Table 70. Genea Limited Company Details
    Table 71. Genea Limited Business Overview
    Table 72. Genea Limited Pre-Implantation Genetic Diagnosis (PGD) Product
    Table 73. Genea Limited Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021) & (US$ Million)
    Table 74. Genea Limited Recent Development
    Table 75. Quest Diagnostics Company Details
    Table 76. Quest Diagnostics Business Overview
    Table 77. Quest Diagnostics Pre-Implantation Genetic Diagnosis (PGD) Product
    Table 78. Quest Diagnostics Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021) & (US$ Million)
    Table 79. Quest Diagnostics Recent Development
    Table 80. Illumina, Inc. Company Details
    Table 81. Illumina, Inc. Business Overview
    Table 82. Illumina, Inc. Pre-Implantation Genetic Diagnosis (PGD) Product
    Table 83. Illumina, Inc. Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021) & (US$ Million)
    Table 84. Illumina, Inc. Recent Development
    Table 85. Natera, Inc. Company Details
    Table 86. Natera, Inc. Business Overview
    Table 87. Natera, Inc. Pre-Implantation Genetic Diagnosis (PGD) Product
    Table 88. Natera, Inc. Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021) & (US$ Million)
    Table 89. Natera, Inc. Recent Development
    Table 90. Cooper Medical, Inc. Company Details
    Table 91. Cooper Medical, Inc. Business Overview
    Table 92. Cooper Medical, Inc. Pre-Implantation Genetic Diagnosis (PGD) Product
    Table 93. Cooper Medical, Inc. Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021) & (US$ Million)
    Table 94. Cooper Medical, Inc. Recent Development
    Table 95. LabCorp Company Details
    Table 96. LabCorp Business Overview
    Table 97. LabCorp Pre-Implantation Genetic Diagnosis (PGD) Product
    Table 98. LabCorp Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021) & (US$ Million)
    Table 99. LabCorp Recent Development
    Table 100. California Pacific Medical Center (CPMC) Company Details
    Table 101. California Pacific Medical Center (CPMC) Business Overview
    Table 102. California Pacific Medical Center (CPMC) Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021) & (US$ Million)
    Table 103. California Pacific Medical Center (CPMC) Recent Development
    Table 104. Thermo Fisher Scientific Inc. Company Details
    Table 105. Thermo Fisher Scientific Inc. Business Overview
    Table 106. Thermo Fisher Scientific Inc. Pre-Implantation Genetic Diagnosis (PGD) Product
    Table 107. Thermo Fisher Scientific Inc. Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021) & (US$ Million)
    Table 108. Thermo Fisher Scientific Inc. Recent Development
    Table 109. IGENOMIX Company Details
    Table 110. IGENOMIX Business Overview
    Table 111. IGENOMIX Pre-Implantation Genetic Diagnosis (PGD) Product
    Table 112. IGENOMIX Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021) & (US$ Million)
    Table 113. IGENOMIX Recent Development
    Table 114. Reproductive Genetic Innovations Company Details
    Table 115. Reproductive Genetic Innovations Business Overview
    Table 116. Reproductive Genetic Innovations Pre-Implantation Genetic Diagnosis (PGD) Product
    Table 117. Reproductive Genetic Innovations Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021) & (US$ Million)
    Table 118. Reproductive Genetic Innovations Recent Development
    Table 119. CombiMatrix Company Details
    Table 120. CombiMatrix Business Overview
    Table 121. CombiMatrix Pre-Implantation Genetic Diagnosis (PGD) Product
    Table 122. CombiMatrix Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021) & (US$ Million)
    Table 123. CombiMatrix Recent Development
    Table 124. Research Programs/Design for This Report
    Table 125. Key Data Information from Secondary Sources
    Table 126. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Type: 2020 VS 2027
    Figure 2. Chromosomal Abnormalities Features
    Figure 3. X-linked Diseases Features
    Figure 4. Freeze Embryo Testing Features
    Figure 5. Aneuploidy Screening Features
    Figure 6. HLA Features
    Figure 7. Others Features
    Figure 8. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Application: 2020 VS 2027
    Figure 9. Stem Cell Therapy Case Studies
    Figure 10. IVF Prognosis Case Studies
    Figure 11. Late-Onset Genetic Disorders Case Studies
    Figure 12. Inherited Genetic Disease Case Studies
    Figure 13. Others Case Studies
    Figure 14. Pre-Implantation Genetic Diagnosis (PGD) Report Years Considered
    Figure 15. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 16. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 17. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Regions: 2020 VS 2027
    Figure 18. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Regions (2022-2027)
    Figure 19. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Players in 2020
    Figure 20. Global Top Pre-Implantation Genetic Diagnosis (PGD) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pre-Implantation Genetic Diagnosis (PGD) as of 2020
    Figure 21. The Top 10 and 5 Players Market Share by Pre-Implantation Genetic Diagnosis (PGD) Revenue in 2020
    Figure 22. Global Pre-Implantation Genetic Diagnosis (PGD) Revenue Market Share by Type (2016-2021)
    Figure 23. Global Pre-Implantation Genetic Diagnosis (PGD) Revenue Market Share by Type (2022-2027)
    Figure 24. North America Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. North America Pre-Implantation Genetic Diagnosis (PGD) Market Share by Type (2016-2027)
    Figure 26. North America Pre-Implantation Genetic Diagnosis (PGD) Market Share by Application (2016-2027)
    Figure 27. North America Pre-Implantation Genetic Diagnosis (PGD) Market Share by Country (2016-2027)
    Figure 28. United States Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. Canada Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Share by Type (2016-2027)
    Figure 32. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Share by Application (2016-2027)
    Figure 33. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Share by Country (2016-2027)
    Figure 34. Germany Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. France Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. U.K. Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Italy Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Russia Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Nordic Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Share by Type (2016-2027)
    Figure 42. Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Share by Application (2016-2027)
    Figure 43. Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Share by Region (2016-2027)
    Figure 44. China Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Japan Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. South Korea Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Southeast Asia Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. India Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Australia Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Share by Type (2016-2027)
    Figure 52. Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Share by Application (2016-2027)
    Figure 53. Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Share by Country (2016-2027)
    Figure 54. Mexico Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Brazil Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Share by Type (2016-2027)
    Figure 58. Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Share by Application (2016-2027)
    Figure 59. Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Share by Country (2016-2027)
    Figure 60. Turkey Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 61. Saudi Arabia Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 62. UAE Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 63. Roche Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021)
    Figure 64. Genea Limited Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021)
    Figure 65. Quest Diagnostics Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021)
    Figure 66. Illumina, Inc. Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021)
    Figure 67. Natera, Inc. Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021)
    Figure 68. Cooper Medical, Inc. Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021)
    Figure 69. LabCorp Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021)
    Figure 70. California Pacific Medical Center (CPMC) Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021)
    Figure 71. Thermo Fisher Scientific Inc. Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021)
    Figure 72. IGENOMIX Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021)
    Figure 73. Reproductive Genetic Innovations Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021)
    Figure 74. CombiMatrix Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021)
    Figure 75. Bottom-up and Top-down Approaches for This Report
    Figure 76. Data Triangulation
    Figure 77. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Roche
Genea Limited
Quest Diagnostics
Illumina, Inc.
Natera, Inc.
Cooper Medical, Inc.
LabCorp
California Pacific Medical Center (CPMC)
Thermo Fisher Scientific Inc.
IGENOMIX
Reproductive Genetic Innovations
CombiMatrix
Frequently Asked Questions
Pre-Implantation Genetic Diagnosis (PGD) report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Pre-Implantation Genetic Diagnosis (PGD) report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Pre-Implantation Genetic Diagnosis (PGD) report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports